Published in Neuropharmacology on December 01, 2001
GABA-induced intersubunit conformational movement in the GABAA receptor alpha 1M1-beta 2M3 transmembrane subunit interface: experimental basis for homology modeling of an intravenous anesthetic binding site. J Neurosci (2009) 1.50
Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation. Mol Pharmacol (2008) 1.47
Numerous classes of general anesthetics inhibit etomidate binding to gamma-aminobutyric acid type A (GABAA) receptors. J Biol Chem (2010) 1.46
A unitary anesthetic binding site at high resolution. J Biol Chem (2009) 1.34
Modes and models of GABA(A) receptor gating. J Physiol (2006) 1.23
A propofol binding site on mammalian GABAA receptors identified by photolabeling. Nat Chem Biol (2013) 1.21
Multiple propofol-binding sites in a γ-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog. J Biol Chem (2014) 1.20
General anesthetic actions on GABA(A) receptors. Curr Neuropharmacol (2010) 1.16
4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor. J Med Chem (2002) 1.11
Time-resolved photolabeling of the nicotinic acetylcholine receptor by [3H]azietomidate, an open-state inhibitor. Mol Pharmacol (2009) 1.05
p-(4-Azipentyl)propofol: a potent photoreactive general anesthetic derivative of propofol. J Med Chem (2011) 1.04
Mutational analysis of molecular requirements for the actions of general anaesthetics at the gamma-aminobutyric acidA receptor subtype, alpha1beta2gamma2. BMC Pharmacol (2003) 1.04
An allosteric coagonist model for propofol effects on α1β2γ2L γ-aminobutyric acid type A receptors. Anesthesiology (2012) 1.03
New insights into the molecular mechanisms of general anaesthetics. Br J Pharmacol (2010) 1.02
Tryptophan and Cysteine Mutations in M1 Helices of α1β3γ2L γ-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site. Anesthesiology (2016) 0.99
A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface. Br J Pharmacol (2012) 0.98
Channel opening by anesthetics and GABA induces similar changes in the GABAA receptor M2 segment. Biophys J (2007) 0.97
Mutations at beta N265 in γ-aminobutyric acid type A receptors alter both binding affinity and efficacy of potent anesthetics. PLoS One (2014) 0.94
A Single phenylalanine residue in the main intracellular loop of α1 γ-aminobutyric acid type A and glycine receptors influences their sensitivity to propofol. Anesthesiology (2011) 0.92
Mutations at F637 in the NMDA receptor NR2A subunit M3 domain influence agonist potency, ion channel gating and alcohol action. Br J Pharmacol (2007) 0.91
The influence of the membrane on neurosteroid actions at GABA(A) receptors. Psychoneuroendocrinology (2009) 0.91
Mechanisms of anesthetic actions and the brain. J Anesth (2007) 0.89
State-dependent etomidate occupancy of its allosteric agonist sites measured in a cysteine-substituted GABAA receptor. Mol Pharmacol (2013) 0.89
Propofol suppresses synaptic responsiveness of somatosensory relay neurons to excitatory input by potentiating GABA(A) receptor chloride channels. Mol Pain (2005) 0.88
The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABA(A) receptors. Neuropharmacology (2012) 0.86
Cysteine substitutions define etomidate binding and gating linkages in the α-M1 domain of γ-aminobutyric acid type A (GABAA) receptors. J Biol Chem (2013) 0.85
The alpha 1 and alpha 6 subunit subtypes of the mammalian GABA(A) receptor confer distinct channel gating kinetics. J Physiol (2004) 0.84
Mechanisms of anabolic androgenic steroid inhibition of mammalian epsilon-subunit-containing GABAA receptors. J Physiol (2006) 0.84
Mutational Analysis of the Putative High-Affinity Propofol Binding Site in Human β3 Homomeric GABAA Receptors. Mol Pharmacol (2015) 0.82
A residue in loop 9 of the beta2-subunit stabilizes the closed state of the GABAA receptor. J Biol Chem (2009) 0.82
Low dose of fentanyl reduces predicted effect-site concentration of propofol for flexible laryngeal mask airway insertion. J Anesth (2009) 0.81
Propofol shares the binding site with isoflurane and sevoflurane on leukocyte function-associated antigen-1. Anesth Analg (2013) 0.80
Use of concatemers of ligand-gated ion channel subunits to study mechanisms of steroid potentiation. Anesthesiology (2011) 0.79
Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism. PLoS One (2016) 0.77
Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What? Front Mol Neurosci (2016) 0.77
Recognition of anesthetic barbiturates by a protein binding site: a high resolution structural analysis. PLoS One (2012) 0.77
General Anesthetic Binding Sites in Human α4β3δ γ-Aminobutyric Acid Type-A Receptors (GABAAR). J Biol Chem (2016) 0.75
Manipulations of extracellular Loop 2 in α1 GlyR ultra-sensitive ethanol receptors (USERs) enhance receptor sensitivity to isoflurane, ethanol, and lidocaine, but not propofol. Neuroscience (2015) 0.75
Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol. Curr Neuropharmacol (2016) 0.75
A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude). Mol Pharmacol (2015) 0.75
Identification of amino acids involved in histamine potentiation of GABA A receptors. Front Pharmacol (2015) 0.75
Curcumol allosterically modulates GABA(A) receptors in a manner distinct from benzodiazepines. Sci Rep (2017) 0.75
A Novel Bifunctional Alkylphenol Anesthetic Allows Characterization of γ-Aminobutyric Acid, Type A (GABAA), Receptor Subunit Binding Selectivity in Synaptosomes. J Biol Chem (2016) 0.75
Contradicting a unitary theory of general anesthetic action: a history of three compounds from 1901 to 2001. Bull Anesth Hist (2003) 0.75
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A (1981) 32.98
Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature (1997) 7.49
Molecular and cellular mechanisms of general anaesthesia. Nature (1994) 6.94
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature (1989) 4.45
The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors. Nature (1987) 4.15
Volume changes on protein folding. Structure (1994) 3.54
The characterization of amino acid sequences in proteins by statistical methods. J Theor Biol (1968) 2.75
The effect of subunit composition of rat brain GABAA receptors on channel function. Neuron (1990) 2.54
Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(A) receptors in hippocampal neurons. Mol Pharmacol (2001) 2.43
General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci (1999) 2.43
Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem (2000) 2.37
Cloning of the gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit highly expressed in the retina. Proc Natl Acad Sci U S A (1991) 2.10
GABAA receptor beta subunit heterogeneity: functional expression of cloned cDNAs. EMBO J (1989) 2.05
Evidence for a common binding cavity for three general anesthetics within the GABAA receptor. J Neurosci (2001) 2.00
p-Cresol methylhydroxylase. Assay and general properties. Biochem J (1985) 1.91
Structural basis for the inhibition of firefly luciferase by a general anesthetic. Biophys J (1998) 1.83
The general anesthetic propofol slows deactivation and desensitization of GABA(A) receptors. J Neurosci (1999) 1.83
The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br J Pharmacol (1991) 1.81
Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol (1998) 1.80
Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem (2000) 1.78
General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility. J Pharmacol Exp Ther (2001) 1.78
Enhancement of glycine receptor function by ethanol is inversely correlated with molecular volume at position alpha267. J Biol Chem (1998) 1.77
Mutations of gamma-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor? Proc Natl Acad Sci U S A (1998) 1.76
Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics. Br J Pharmacol (1996) 1.72
Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations. Mol Pharmacol (1994) 1.57
The crystal structure of phenol hydroxylase in complex with FAD and phenol provides evidence for a concerted conformational change in the enzyme and its cofactor during catalysis. Structure (1998) 1.42
Crystal structures and inhibitor binding in the octameric flavoenzyme vanillyl-alcohol oxidase: the shape of the active-site cavity controls substrate specificity. Structure (1997) 1.39
Sequence and expression of human GABAA receptor alpha 1 and beta 1 subunits. FEBS Lett (1989) 1.39
Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors. Mol Pharmacol (1993) 1.34
Gamma-aminobutyric acid increases the water accessibility of M3 membrane-spanning segment residues in gamma-aminobutyric acid type A receptors. Biophys J (1999) 1.32
Amino acid volume and hydropathy of a transmembrane site determine glycine and anesthetic sensitivity of glycine receptors. J Biol Chem (1999) 1.30
A single hydrophobic residue confers barbiturate sensitivity to gamma-aminobutyric acid type C receptor. Mol Pharmacol (1999) 1.26
Inhibition of rho1 receptor GABAergic currents by alcohols and volatile anesthetics. J Pharmacol Exp Ther (1996) 1.24
Propofol activates GABAA receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology (1993) 1.23
Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents. J Med Chem (1980) 1.20
Biophysical and pharmacological properties of cloned GABAA receptor subunits expressed in Xenopus oocytes. Neuron (1988) 1.18
Subunit mutations affect ethanol actions on GABA(A) receptors expressed in Xenopus oocytes. Br J Pharmacol (1999) 1.16
The actions of ether, alcohol and alkane general anaesthetics on GABAA and glycine receptors and the effects of TM2 and TM3 mutations. Br J Pharmacol (2000) 1.16
Structures of the flavocytochrome p-cresol methylhydroxylase and its enzyme-substrate complex: gated substrate entry and proton relays support the proposed catalytic mechanism. J Mol Biol (2000) 1.15
Alcohol action on a neuronal membrane receptor: evidence for a direct interaction with the receptor protein. Proc Natl Acad Sci U S A (1994) 1.09
Agonist gating and isoflurane potentiation in the human gamma-aminobutyric acid type A receptor determined by the volume of a second transmembrane domain residue. Mol Pharmacol (1999) 1.08
Tryptophan scanning mutagenesis in TM2 of the GABA(A) receptor alpha subunit: effects on channel gating and regulation by ethanol. Br J Pharmacol (2000) 1.07
Mutation at the putative GABA(A) ion-channel gate reveals changes in allosteric modulation. Br J Pharmacol (1999) 1.01
Cutoff in potency implicates alcohol inhibition of N-methyl-D-aspartate receptors in alcohol intoxication. Proc Natl Acad Sci U S A (1995) 1.00
Regio- and stereospecific conversion of 4-alkylphenols by the covalent flavoprotein vanillyl-alcohol oxidase. J Bacteriol (1998) 0.99
Chemical properties of alcohols and their protein binding sites. Cell Mol Life Sci (2000) 0.99
Engineering yeast alcohol dehydrogenase. Replacing Trp54 by Leu broadens substrate specificity. Protein Eng (1995) 0.98
Trichloroethanol modulation of recombinant GABAA, glycine and GABA rho 1 receptors. J Pharmacol Exp Ther (1998) 0.98
General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends Pharmacol Sci (1999) 0.97
Arg-274 and Leu-277 of the gamma-aminobutyric acid type A receptor alpha 2 subunit define agonist efficacy and potency. J Biol Chem (2000) 0.88
Is there a general anesthesia receptor. Can J Physiol Pharmacol (1981) 0.81
Modified substrate specificity of L-hydroxyisocaproate dehydrogenase derived from structure-based protein engineering. Protein Eng (1997) 0.77
Proposed uniform nomenclature for mammalian ribosomal proteins. Mol Gen Genet (1979) 13.52
Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev (1993) 10.01
Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell (1995) 9.30
Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature (1997) 7.49
Cell-free translation reconstituted with purified components. Nat Biotechnol (2001) 6.55
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A (1991) 6.42
Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science (1994) 6.07
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
Inhibition of JNK activation through NF-kappaB target genes. Nature (2001) 5.03
A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet (1999) 4.96
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science (1986) 4.44
Codon and amino-acid specificities of a transfer RNA are both converted by a single post-transcriptional modification. Nature (1988) 4.17
A tRNA-like structure is present in 10Sa RNA, a small stable RNA from Escherichia coli. Proc Natl Acad Sci U S A (1994) 3.74
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med (2000) 3.74
Nucleotide sequence of 5 S RNA from Torulopsis utilis. FEBS Lett (1974) 3.70
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Genome-wide epistatic interaction analysis reveals complex genetic determinants of circadian behavior in mice. Genome Res (2001) 3.04
Protein structure comparison using the markov transition model of evolution. Proteins (2000) 2.94
The Protein Mutant Database. Nucleic Acids Res (1999) 2.87
Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol (1991) 2.79
The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine (1998) 2.70
Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol (1985) 2.67
Mixed infections with Opisthorchis viverrini and intestinal flukes in residents of Vientiane Municipality and Saravane Province in Laos. J Helminthol (2005) 2.62
GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc Natl Acad Sci U S A (2006) 2.53
Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology (1983) 2.53
Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene. J Virol (1988) 2.44
General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci (1999) 2.43
c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol (1994) 2.41
Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett (1998) 2.40
Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J Virol (1988) 2.38
Targeting and function in mRNA export of nuclear pore complex protein Nup153. J Cell Biol (1996) 2.38
Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest (1999) 2.26
The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J (1996) 2.22
Chloroplast transit peptides. The perfect random coil? FEBS Lett (1991) 2.20
Exclusive expression of C. elegans osm-3 kinesin gene in chemosensory neurons open to the external environment. J Mol Biol (1995) 2.20
Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci U S A (1997) 2.16
Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J Virol (1988) 2.12
Discrimination of intracellular and extracellular proteins using amino acid composition and residue-pair frequencies. J Mol Biol (1994) 2.11
Trifluoroethanol-induced stabilization of the alpha-helical structure of beta-lactoglobulin: implication for non-hierarchical protein folding. J Mol Biol (1995) 2.09
The folding type of a protein is relevant to the amino acid composition. J Biochem (1986) 2.07
Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex. J Pharmacol Exp Ther (1987) 2.01
Evidence for a common binding cavity for three general anesthetics within the GABAA receptor. J Neurosci (2001) 2.00
Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A (2001) 1.99
Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol (1998) 1.99
Parenchymal transection of the kidney inflicted by endocatch bag entrapment during a laparoscopic donor nephrectomy. Am J Transplant (2006) 1.95
Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care (1999) 1.90
Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J Biol Chem (1998) 1.87
The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity. J Biol Chem (1999) 1.86
Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab (2001) 1.84
Sequence of the amino-terminal region of rat liver ribosomal proteins S4, S6, S8, L6, L7a, L18, L27, L30, L37, L37a, and L39. J Supramol Struct (1979) 1.82
Serine tRNA complementary to the nonuniversal serine codon CUG in Candida cylindracea: evolutionary implications. Proc Natl Acad Sci U S A (1992) 1.82
Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res (1984) 1.81
Structure and function of 5S ribosomal ribonucleic acid from Torulopsis utilis. II. Partial digestion with ribonucleases and derivation of the complete sequence. J Biochem (1974) 1.81
The primary structure of rat ribosomal protein L7. The presence near the amino terminus of L7 of five tandem repeats of a sequence of 12 amino acids. J Biol Chem (1987) 1.81
Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol (1998) 1.80
General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility. J Pharmacol Exp Ther (2001) 1.78
Enhancement of glycine receptor function by ethanol is inversely correlated with molecular volume at position alpha267. J Biol Chem (1998) 1.77
Mutations of gamma-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor? Proc Natl Acad Sci U S A (1998) 1.76
Domain dislocation: a change of core structure in periplasmic binding proteins in their evolutionary history. J Mol Biol (1999) 1.73
Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes. J Virol (1989) 1.71
A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology (2001) 1.70
Structure and regulation of rat long-chain acyl-CoA synthetase. J Biol Chem (1990) 1.68
Sequence specificity of mRNA N6-adenosine methyltransferase. J Biol Chem (1990) 1.67
The conserved npl4 protein complex mediates proteasome-dependent membrane-bound transcription factor activation. Mol Biol Cell (2001) 1.66
Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase. Mol Cell Biol (1998) 1.65
Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform. Biophys J (1997) 1.65
Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol (1998) 1.63
Human RecQ5beta, a large isomer of RecQ5 DNA helicase, localizes in the nucleoplasm and interacts with topoisomerases 3alpha and 3beta. Nucleic Acids Res (2000) 1.63
Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. AJR Am J Roentgenol (1994) 1.62
The primary structure of rat ribosomal protein L19. A determination from the sequence of nucleotides in a cDNA and from the sequence of amino acids in the protein. J Biol Chem (1987) 1.57
Homology between mammalian DNA polymerase beta and terminal deoxynucleotidyltransferase. J Biol Chem (1987) 1.57
Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51. Genes Cells (2001) 1.54
CV-3988 - a specific antagonist of platelet activating factor (PAF). Life Sci (1983) 1.52
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis (2000) 1.51
Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur J Pharmacol (1985) 1.50
Genes from nine genomes are separated into their organisms in the dinucleotide composition space. DNA Res (1998) 1.49
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology (2001) 1.49
The primary structure of rat ribosomal protein S8. Nucleic Acids Res (1987) 1.48
Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidney. Nature (1977) 1.48
Detection and direct typing of herpes simplex virus by polymerase chain reaction. Med Microbiol Immunol (1990) 1.47
Differential regulation of human RecQ family helicases in cell transformation and cell cycle. Oncogene (2000) 1.46
Low-energy structures of two dipeptides and their relationship to bend conformations. Macromolecules (1975) 1.45
The homeobox protein Six3 interacts with the Groucho corepressor and acts as a transcriptional repressor in eye and forebrain formation. Dev Biol (2001) 1.45
Higher-order structure of bovine mitochondrial tRNA(Phe) lacking the 'conserved' GG and T psi CG sequences as inferred by enzymatic and chemical probing. Nucleic Acids Res (1994) 1.43
Optical isomers open a new window on anesthetic mechanism. Anesthesiology (1998) 1.43
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer. Cancer Gene Ther (2006) 1.43
T-cell receptors are expressed but down-regulated on intradecidual T lymphocytes. Am J Reprod Immunol (1993) 1.43
Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney. J Clin Invest (1977) 1.42
FasL is important in costimulation blockade-resistant skin graft rejection. Transplantation (2001) 1.39
Amino acid sequence homology applied to the prediction of protein secondary structures, and joint prediction with existing methods. Biochim Biophys Acta (1986) 1.39
Identification of a gene family (kat) encoding kinesin-like proteins in Arabidopsis thaliana and the characterization of secondary structure of KatA. Mol Gen Genet (1993) 1.39
The HLA-G 14 bp insertion/deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children. Tissue Antigens (2009) 1.39
Intraoperative QRS-interval changes caused by hyperkalaemia in an infant with Arima syndrome. Paediatr Anaesth (1998) 1.39
Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38. J Biol Chem (1997) 1.36
Transcriptive complex of Newcastle disease virus. II. Structural and functional assembly associated with the cytoskeletal framework. Virology (1985) 1.36
The primary structure of the acidic phosphoprotein P2 from rat liver 60 S ribosomal subunits. Comparison with ribosomal 'A' proteins from other species. J Biol Chem (1982) 1.34
Potentiation of gamma-aminobutyric-acid-activated chloride conductance by a steroid anaesthetic in cultured rat spinal neurones. J Physiol (1987) 1.34
Effects of volatile anesthetics on the kinetics of inhibitory postsynaptic currents in cultured rat hippocampal neurons. J Neurophysiol (1993) 1.33
Enhancement of gamma-aminobutyric acid-activated Cl- currents in cultured rat hippocampal neurones by three volatile anaesthetics. J Physiol (1992) 1.33